
|Articles|December 1, 2002
Supplements and Featured Publications
- Health-Related Consequences of and Treatment Strategies for Overactive Bladder
- Volume 8
- Issue 19 Suppl
Health-Related Quality of Life Patients Receiving Extended-Release Tolterodine for Overactive Bladder
Advertisement
Articles in this issue
about 23 years ago
Participating Facultyabout 23 years ago
Health-Related Consequences of Overactive BladderNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Pirtobrutinib Outperforms Bendamustine-Rituximab in Frontline CLL/SLL
4
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
5










































